This study investigated the influence of glycans on the activity of the myeloperoxidase enzyme (MPO), and the binding capacity of its physiological inhibitor ceruloplasmin and autoimmune antibodies (MPO-ANCA). Deglycosylated MPO was less antigenic to MPO-ANCA, had less enzymatic activity and did not bind to ceruloplasm. These data demonstrate the importance of MPO glycosylation for its function and role in autoimmune vasculitis.
arately. The chlorination activity of MPO, the binding between ceruloplasmin and MPO, and the reversing effect of MPO-ANCA to this binding were measured. Three de-glycosylated MPOs were used to assay the influence of deglycosylation on microbicidal effect of MPO.
Results: Compared with intact MPO, chlorination activity of deglycosylated MPO declined, in which removing of β-galactopyranoside (0.35 ± 0.02 vs. 0.50 ± 0.04, P < 0.001) and α-linked sialic acid (0.35 ± 0.02 vs. 0.50 ± 0.04, P < 0.001) presented the most significance. Deglycosylation reduced the binding capacity between MPO and its physiological inhibitor-ceruloplasmin, with the most significance on the removal of innermost GlcNAc (0.37 ± 0.04 vs. 1.06 ± 0.11, P < 0.001). Binding between MPO and ceruloplasmin was hardly reversed by MPO-ANCA after deglycosylation, especially on the removal of α-linked sialic acid (71.2 ± 5.1% vs. 88.3 ± 1.0%, P = 0.009), chitobiose core (73.6 ± 1.9% vs. 88.3 ± 1.0%, P = 0.001) and GlcNAc (77.9 ± 1.9% vs. 88.3 ± 1.0%, P = 0.002). Removal of innermost GlcNAc, β-galactopyranoside and α-neuraminidase could weaken the bactericidal effect of MPO, especially the removal of α-neuraminidase (P < 0.001).
Conclusions: Deglycosylation decreased oxidation activity of MPO and its binding with ceruloplasmin. Deglycosylation could also decrease the microbicidal effect of MPO, which might contribute to more severe infections and inflammation. Deglycosylated MPO presented less antigenicity to MPO-ANCA, which indicated the contribution of glycans to MPO epitopes.
Kidneys are one of the most common target organs of antineutrophil cytoplasmic autoantibodies (ANCA)-associated systemic vasculitis; the condition may sometimes present as 'kidney-limited ' vasculitis. Proteinase-3 (PR3) and myeloperoxidase (MPO) are the two major target antigens of ANCA. MPO-ANCA was reported to be more predominant in Chinese patients. 1 Both MPO-ANCA complex and MPO itself have been shown to be pathogenic. [2] [3] [4] [5] Furthermore, linear epitopes on MPO were reported in ANCA-negative vasculitis, 6 and occult antibodies against these linear epitopes were blocked in serum by a ceruloplasmin fragment, which further proves the pathogenicity of MPO itself and occurrence of special anti-MPO autoantibodies in ANCA-negative vasculitis.
Myeloperoxidase is also one of the major proteins of the antimicrobial system in mammalian neutrophils. 2 It catalyzes the production of hypochlorous acid, a potent reactive oxygen species, from hydrogen peroxide (H 2 O 2 ) and chloride ions (Cl À ). [7] [8] [9] However, the reactive oxygen species produced by the catalytic activity of MPO has been shown to contribute to tissue damage in certain inflammatory diseases such as, rheumatoid arthritis, atherosclerosis and multiple sclerosis. 2 Under physiological conditions, the peroxidase activity of MPO is inhibited by ceruloplasmin, which is a multi-functional copper containing protein that oxidizes the highly toxic ferrous ions of MPO to ferric state. 7, 8 Increased levels of ceruloplasmin and its high affinity for binding to MPO has been demonstrated in patients with active MPO-ANCA vasculitis. 6 However, the inhibitory effect of ceruloplasmin on MPO can be disturbed in the presence of MPO-ANCA, which may result in the persistent generation of reactive oxygen by MPO and lead to endothelial insult. 4 Myeloperoxidase is a glycosylated hemo-enzyme, which is most abundantly present in neutrophils. The mature MPO protein consists of two light and two heavy polypeptide chains with each heavy chain binding to prosthetic heme group. 10 Mass spectrometry has demonstrated the presence of five Nlinked glycosylation sites in each MPO heavy chain, which are occupied by either complex or high mannose glycan structures. 11 The overall structures of MPO glycan and the biological effects of glycosylation patterns on MPO function are not well characterized. In our previous study involving patients with ANCAassociated vasculitis, the MPO-ANCA positive sera recognized linear peptides in the N-terminal part of MPO heavy chain, especially H1 279-409. 12 We further found that the major epitopes in this peptide were located at H4 and H11. 13 Each of these two regions contain one N-linked glycosylation site on MPO.
We hypothesized that the glycosylation of MPO may influence its antigenicity as well as its functions as a peroxidase. Oxidation and antimicrobial activity are two major functions of MPO under physiological conditions, and ceruloplasmin prevents overactivation of MPO. In ANCA-associated vasculitis, the inhibitory effect of ceruloplasmin on MPO is disturbed because of MPO-ANCA. Therefore, we conducted a study to investigate the influence of glycans on the chlorination activity and microbicidal effect of MPO, on the binding capacity of ceruloplasmin to MPO, and the effect of MPO-ANCA on this binding. The objective was to explore the influence of glycosylation patterns on MPO functions and the potential role in the pathogenesis of ANCA associated vasculitis.
METHODS

Deglycosylation of MPO by glycosidases
Human leukocyte myeloperoxidase (Calbiochem, Billerica, MA, USA) was deglycosylated according to the respective standard protocols of Peptide-N-Glycosidase F (PNGase-F) kit (New England Biolabs, Swich, MA, USA), α-neuraminidase (Roche, Mannheim, Germany), α1,6 fucosidase (Sigma, St Louis, MO, USA), β-galactosidase (Sigma, St Louis, MO, USA), β-mannosidase (Sigma, St Louis, MO, USA), α1-2,3 mannosidase kit (New England Biolabs, Swich, MA, USA), α1, 6 mannosidase kit (New England Biolabs, Swich, MA, USA) and Endo H kit (New England Biolabs, Swich, MA,USA), respectively.
To remove the link between the innermost Nacetylglucosamine (GlcNAc) and asparagine residues from MPO, 10 μL human MPO (1 mg/mL) was incubated overnight at 37°C with 2 μL PNGase-F, 2 μL 10× G7 reaction buffer (500 mM sodium phosphate, pH 7.5), and 6 μL protease inhibitor diluent (Calbiochem, Billerica, MA, USA). To remove α2,3, α2,6 and α2,8-linked sialic acid from the N-glycan of MPO, 10 μL human MPO (1 mg/mL) were incubated overnight at 37°C with 6.25 μL α-neuraminidase, 33.75 μL reaction buffer (50 mM sodium citrate, pH 5). To remove branched terminal fucose from the N-glycan of MPO, 10 μL human MPO (1 mg/ mL) were incubated overnight at 37°C with 2 μL α1, 6 fucosidase, 3 μL reaction buffer (50 mM sodium phosphate, pH 5). To remove β-galactopyranoside from MPO, 10 μL human MPO (1 mg/mL) were incubated overnight at 37°C with 2.5 μL β-galactosidase (diluted to 1 U/mL with deionized water), 37.5 μL reaction buffer (100 mM sodium phosphate, 30 mM magnesium chloride, pH 7.3).
To remove β-linked mannose residues from MPO, 10 μL human MPO (1 mg/mL) were incubated overnight at 37°C with 5 μL β-mannosidase (diluted to 1 U/mL with deionized water), 35 μL reaction buffer (50 mM sodium citrate, pH 4). To remove α1-2 and α1-3 linked D-mannopyranosyl residues from MPO, 8 μL human MPO (1 mg/mL) were incubated overnight at 37°C with 1 μL α1-2,3 mannosidase, 1 μL 10 × G6 reaction buffer (50 mM sodium acetate, 5 mM CaCl 2 , pH 5.5).
To remove unbranched α1, 6 mannopyranosyl from MPO, 8 μL human MPO (1 mg/mL) were incubated overnight at 37°C with 1 μL α1, 6 mannosidase, 1 μL 10 × G2 reaction buffer (50 mM sodium citrate, pH 4.5). To remove chitobiose core, 8 μL human MPO (1 mg/mL) were incubated overnight at 37°C with 1 μL Endo H, 1 μL 10 × G5 reaction buffer (500 mM sodium citrate, pH 5.5).
The glycans removed from MPO are shown in Figure 1 according to the classical structure of high-mannose and complex N-linked glycoproteins. 14 
Influence of various glycans on the chlorination activity of MPO
Myeloperoxidase (4 μg/mL) was diluted in 0.01 M phosphate buffered saline (PBS) with Cl À concentration of 137 mmol/L and then coated on polystyrene microtitre plates (Nunc Immunoplate, Roskilde, Denmark) at 37°C for 1 h. After three washes with PBS, the plates were incubated with 30% H 2 O 2 and 0.4 g/L o-Phenylenediamine (Sigma, St Louis, MO, USA) in PBS. 15 The absorbance value was measured at 450 nm every 2 min. The same procedure was repeated four times and the mean level at each time-point obtained. Different kinds of deglycosylated MPO were coated on the plates and the same experiments were performed to measure the influence of various glycans on the chlorination activity of MPO.
innermost GlcNAc, β-galactosidase, and α-neuraminidase. The bacteria were cultured overnight (about 16 h) in Luria Broth (LB) at 37°C, centrifuged at 1962 g for 15 min and resuspended with normal saline. The colony forming units (cfu) was estimated by measuring OD600 of bacteria suspension. About 10 8 cfu/mL ATCC6538 was incubated with 2 units/mL of different patterns of MPOs at 37°C for 15 min. Then 0.8 mM H 2 O 2 and 1 mM potassium iodide (KI) were added to the reaction system. After incubation at 37°C for 30 min, the mixtures were inoculated in LB medium and incubated overnight at 37°C. The microbicidal actions were assessed by measuring OD600 of bacterial suspensions; each assay was repeated four times. 16 Influence of various glycans on the binding capacity of ceruloplasmin to MPO Myeloperoxidase (3 μg/mL) was diluted in coating buffer (0.05 M carbonate buffer, pH 9.6) and coated on polystyrene microtitre plates (Nunc Immunoplate, Roskilde, Denmark) at 37°C for 1 h. Human ceruloplasmin (Sigma, St Louis, MO, USA) diluted to a range of physical concentrations (0-640 μg/mL) with PBS containing 0.1% Tween-20 (PBST) was added and incubated at 37°C for 2 h. After repeated washing with PBST, goat anti-ceruloplasmin sera (Sigma, St Louis, MO, USA) diluted at 1:1000, and alkaline phosphatase-conjugated rabbit anti-goat IgG (Sigma, St Louis, MO, USA) at 1:20 000 were added subsequently. P-nitrophenylphosphate (pNPP) was used in substrate buffer [4, 5, 12] . The absorbance value was measured at 405 nm. All incubations were 100 μL/well at 37°C for 1 h, with three washes by PBST between steps. Antigen-free wells were included for each sample. The same procedures were repeated four times. Different kinds of deglycosylated MPO were coated on the plates to measure the influence of various glycans on the binding capacity of MPO to ceruloplasmin.
Purification of MPO-ANCA
Myeloperoxidase-anti-neutrophil cytoplasmic antibodies immunoglobulin G (IgG) was prepared from two patients with active MPO-ANCA positive vasculitis. Informed consent was obtained from each patient prior to collection of blood samples. The research was in compliance with the declaration of Helsinki and approved by the ethics committee at the Peking University First Hospital. Myeloperoxidase was purified from human polymorphonuclear neutrophils isolated from buffy coats as described previously. 17, 18 Purified MPO (1.5 mg) was coupled to 1.5 mL cyanogen bromide-activated Sepharose 4B gel (0.7 g, Amersham Pharmacia, Uppsala, Sweden) with 0.1 M sodium bicarbonate (NaHCO 3 ) and 0.5 M sodium chloride (NaCl; pH 8.3) as coupling buffer at room temperature for 2 h, and blocked with 0.2 M glycine (pH 8.0) at room temperature for 2 h. Total IgGs were purified using a High-Trap-protein G column on an AKTA-FPLC system (GE Biosciences, South San Francisco, CA, USA), with 0.01 M PBS (pH 7.4) as starting buffer and 0.1 M glycine (pH 2.7) as eluting buffer, at a flow rate of 1 mL/min at room temperature. Total IgG was eluted and neutralized to pH 7.0 by 2 M Tris-HCl (pH 9.0) immediately, and dialyzed overnight against PBS. MPO-ANCA IgG was purified from total IgG, with MPO-affinity chromatography and the same method mentioned above. Influence of various glycans on the inhibitory effect of MPO-ANCA on the binding between deglycosylated MPO and ceruloplasmin ELISA assay was performed as described previously with minor modifications. 4 MPO (2 μg/mL) was diluted in coating buffer (0.05 M carbonate buffer, pH 9.6) and then coated on polystyrene microtitre plates (Nunc Immunoplate, Roskilde, Denmark) at 37°C for 1 h. Affinity-purified antibodies to intact MPO (MPO-ANCA) (100 μg/mL) were diluted with 1% bovine serum albumin (BSA) in PBST and incubated at 37°C for 1 h. Then human ceruloplasmin (100 μg/mL) was added and incubated for 1 h. Finally, the binding was measured as described above. The reversing effect of MPO-ANCA was presented as the percentage of the decline of MPO and ceruloplasmin binding after addition of ANCA:
[OD (MPO + ceruloplasmin) -OD (MPO + ceruloplasmin + MPO-ANCA)] / OD (MPO + ceruloplasmin) × 100% different kinds of deglycosylated MPO were coated on the plates and the equation was used to test the influence of various glycans on the reversal effect of ANCA on the binding between MPO and ceruloplasmin. Each assay was repeated four times.
Statistical analysis
Data pertaining to quantitative variables are expressed as Mean ± Standard deviation (SD); between-group differences were assessed by t test. Data from intact MPO was used as control. A P-value <0.05 was considered indicative of a statistically significant difference. Analysis was performed with SPSS statistical software package, version 13 (SPSS Inc., Chicago, IL, USA).
RESULTS
Influence of various glycans on the chlorination activity of MPO
As shown in Figure 2 , the enzyme activity of intact MPO increased gradually and reached steady state at one hour. Intact MPO exhibited highest activity of chlorination with an absorbance value of 0.50 ± 0.04. The enzyme activity of deglycosylated MPO decreased significantly throughout the incubation period. Removal of β-galactopyranoside (0.35 ± 0.02 vs. 0.50 ± 0.04, P < 0.001) and α-linked sialic acid (0.35 ± 0.02 vs. 0.50 ± 0.04, P < 0.001) exhibited the most remarkable decline in enzyme activity of MPO (Table 1) .
Removal of β-mannopyranosyl, α1, 6 linked mannopyranosyl, chitobiose core as well as innermost GlcNAc also decreased the enzyme activity of MPO significantly, but not as significant as that observed with β-galactopyranoside and α-linked sialic acid. The removal of α1, 6 fucose (0.47 ± 0.05 vs. 0.50 ± 0.04, P = 0.282) and α1-2, 3 mannopyranosyl (0.46 ± 0.04 vs. 0.50 ± 0.04, P = 0.199) had no significant effect on the enzyme activity of MPO (Table 1) .
Microbicidal functions of deglycosylated MPOs on ATCC6538
Removal of innermost GlcNAc, β-galactopyranoside and α-linked sialic acid weakened the bactericidal effects of MPO were weakened (Fig. 3) . Removal of α-linked sialic acid had the most remarkable effect on the bactericidal activity of MPO (P < 0.001). Removal of innermost GlcNAc (P = 0.002) and β-galactopyranoside (P = 0.001) also attenuated the bactericidal effect of MPO.
Influence of various glycans on the binding between ceruloplasmin and MPO
As shown in Figure 4 , ceruloplasmin could bind to MPO in a dose dependent manner within the physiological reference range of ceruloplasmin (0 to 640 μg/mL). Intact MPO exhibited the strongest binding capacity to ceruloplasmin, with the highest binding absorbance value of 1.06 ± 0.11. After the removal of glycans on MPO, the binding capacity of MPO to ceruloplasmin decreased significantly, except for α1, 6 fucose (P > 0.05), irrespective of the concentrations of ceruloplasmin.
Removal of different glycans led to variable decline in MPO binding with ceruloplasmin. The most significance effect was observed on removal of innermost GlcNAc at the asparagine residues of MPO (0.37 ± 0.04 vs. 1.06 ± 0.11, P < 0.001) ( Table 2) .
Influence of various glycans on the inhibitory effect of MPO-ANCA on the binding between deglycosylated MPO and ceruloplasmin
The binding between ceruloplasmin and MPO was reversed by MPO-ANCA. The reversal effect of MPO-ANCA on the binding between intact MPO and ceruloplasmin was 88.3 ± 1.0% (Table 3) . After treatment of MPO with different glycosidases, the reversal effect of MPO-ANCA changed accordingly. Removal of α-linked sialic acid (71.2 ± 5.1% vs. 88.3 ± 1.0%, P = 0.009), α1-2,3 linked mannopyranosyl (62.2 ± 8.6% vs. 88.3 ± 1.0%, P = 0.048), chitobiose core (73.6 ± 1.9% vs. 88.3 ± 1.0%, P = 0.001), β-mannopyranosyl (69.9 ± 5.6% vs. 88.3 ± 1.0%, P = 0.039) and innermost GlcNAc (77.9 ± 1.9% vs. 88.3 ± 1.0%, P = 0.002) from MPO significantly reduced the inhibitory effect of MPO-ANCA on the binding between MPO and ceruloplasmin (Table 3) . However, the removal of the other three glycans, i.e., α1, 6 mannopyranosyl, β-galactopyranoside and α1, 6 fucose had no significant effect on the reversal ability of MPO-ANCA (P > 0.05).
DISCUSSION
As a peroxidase, the most vital physiological function of MPO is determined by its enzymatic activity, to catalyze the production of hypochlorous acid and reactive oxygen species, and to participate in the antimicrobial mechanism in circulation and at sites of inflammation. 2 A recent study indicated glycosylation as being critical to the enzymatic activity of MPO
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; our results are consistent in this respect. We further investigated the effect of each glycan on the oxidation function of MPO.
Among the eight different glycans, β-galactopyranoside and α-linked sialic acid appear to be essential, since the microbicidal effect of MPO showed a significant attenuation after the removal of β-galactopyranoside and α-linked sialic acid. These findings underline the important role of glycans in the physiological functions of MPO. The rigid heme architecture is essential to the enzyme activity of peroxidase, and the glycans are closely configured around the heme pocket. 19, 20 The change of glycans may modify the overall protein structure, alter the heme pocket and affect the interaction of MPO with its substrates. 3, 21 Sialic acid and β-galactopyranoside are always located on the terminus of sugar chains. Their loss may have a considerable influence on the conformational structure, thereby attenuating the enzymatic activity of MPO. 21, 22 Deglycosylated MPO is very likely to exist in human circulation via the mechanism of major-and minor-microheterogeneity of N-glycans on mature dimeric MPO. 11 In a study on α1-acid glycoprotein (AGP), Ceciliani, et al. 21 suggested that the change in branching degree, namely major-microheterogeneity, as well as the change of fucosylation and sialic acid numbers, namely minor-microheterogeneity, both influence AGP's biological activity, including its binding properties to pathogenic microorganisms and its immunomodulatory function. These findings imply that the different glycosylation patterns of MPO, mediated by microheterogeneity, may also influence the enzymatic activity of MPO in circulation. More infections in older people, together with high prevalence of MPO-ANCA associated vasculitis in older people support our hypothesis that deglycosylated MPO may be more common in older people, and attenuate the bactericidal function, and increase susceptibility to infections and vasculitis. This mechanism may enhance the pathogenesis of ANCA associated vasculitis.
In the pathogenesis of autoimmune diseases, MPO contribute to inflammatory tissue damage. 2 Ceruloplasmin levels within the physiological range inhibit the peroxidase activity of MPO by binding to it and forming binary complexes with cationic MPO. 7, 8 The modelled loop between ceruloplasmin domains (aa885-892) contacts MPO in the vicinity of heme pocket 23 and the position of loop changes upon binding to avoid stearic clashes. 8 Wujek et al. found an increase in the activity of human tripeptidyl-peptidase I after treatment with Endo H, which was attributable to the stearic hindrance on the catalytic cleft of the enzyme in that its absence facilitated the interaction between the substrate and the catalytic pocket. 24 If the innermost GlcNAc on MPO were removed, most glycans were lost accordingly, which facilitated the binding between the substrate and the catalytic pocket, and attenuated the inhibition from ceruloplasmin. We observed a remarkable decrease in MPO binding to ceruloplasmin after treatment with Endo H, which may have led to the decline or even loss of the protective effect of ceruloplasmin, rather than to a continuous activation of peroxidase, and more severe damage on the inflammatory tissue.
Persistent inflammatory response has been documented in the initiation of ANCA associated vasculitis and is also related to the relapse of disease. 2 The deglycosylated MPO may be a key element contributing to the inflammatory process and to the development of vasculitis. ANCA could reverse the inhibitory effect of ceruloplasmin on MPO, which has been proven in the mechanism of ANCA associated vasculitis 4 and was demonstrated in this study as well. The antibodies did not, of themselves, inhibit the MPO activity, but the epitopes recognized by antibodies may be close to the active site where the interaction with ceruloplasmin likely occurs. 4 In our study, when MPO was deglycosylated, it was hard for MPO-ANCA to reverse the binding of MPO and ceruloplasmin. It is implied that change in glycans on MPO may alter its antigenicity, and render it hard to be recognized by MPO-ANCA. We found that the removal of α-sialic acid, chitobiose core and innermost GlcNAc significantly reduced the reversal effect of MPO-ANCA, which suggests that the epitopes on MPO were, in particular, affected by these glycans. Sialic acids are located at the terminal positions of oligosaccharide chains of N-glycans. 25, 26 Its loss may modulate the stearic hindrance of MPO and influence its binding to MPO-ANCA. On the contrary, the chitobiose core and the innermost GlcNAc are inner glycans on MPO. When these were removed, it led to generous deglycosylation of MPO, and a significant change in the molecular structure. 11 The epitopes on MPO may be altered accordingly thereby reducing its binding to ANCA. Whether the deglycosylated MPO possess its own antibodies needs further investigation. In summary, the loss of glycan terminus decreased the enzymatic activity and microbicidal effect of MPO, which may potentially lead to severe infections. The loss of innermost glycans decreased the binding of ceruloplasmin to MPO, which may be a key mechanism for the sustained inflammatory tissue damage in ANCA associated vasculitis. Further studies on MPO 
